CN1302796C - Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method - Google Patents
Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method Download PDFInfo
- Publication number
- CN1302796C CN1302796C CNB2004100245221A CN200410024522A CN1302796C CN 1302796 C CN1302796 C CN 1302796C CN B2004100245221 A CNB2004100245221 A CN B2004100245221A CN 200410024522 A CN200410024522 A CN 200410024522A CN 1302796 C CN1302796 C CN 1302796C
- Authority
- CN
- China
- Prior art keywords
- radix
- semen
- traditional chinese
- filtrate
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 28
- 241000287828 Gallus gallus Species 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000006188 syrup Substances 0.000 claims abstract description 7
- 235000020357 syrup Nutrition 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 239000006187 pill Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 36
- 239000000706 filtrate Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- -1 filtered Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 241000005787 Cistanche Species 0.000 claims description 8
- 241000190633 Cordyceps Species 0.000 claims description 8
- 244000268590 Euryale ferox Species 0.000 claims description 8
- 235000006487 Euryale ferox Nutrition 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 210000003038 endothelium Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 240000001008 Dimocarpus longan Species 0.000 claims description 6
- 235000000235 Euphoria longan Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 210000000078 claw Anatomy 0.000 claims description 2
- 210000003746 feather Anatomy 0.000 claims description 2
- 210000000936 intestine Anatomy 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- 229960001375 lactose Drugs 0.000 claims 1
- 229940057948 magnesium stearate Drugs 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 238000002512 chemotherapy Methods 0.000 abstract description 9
- 201000002364 leukopenia Diseases 0.000 abstract description 8
- 231100001022 leukopenia Toxicity 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 241000133134 Saussurea Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 10
- 206010016256 fatigue Diseases 0.000 description 8
- 206010003549 asthenia Diseases 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 108010052008 colla corii asini Proteins 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010024419 Libido decreased Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | The example number | Produce effects | Effectively | Invalid | Obvious effective rate | Total effective rate |
The test group matched group | 137 68 | 85 27 | 46 31 | 6 10 | 62.0% 39.7% | 95.6% 85.3% |
Group | The example number | Produce effects | Effectively | Invalid | Obvious effective rate | Total effective rate |
The test group matched group | 30 30 | 12 13 | 16 14 | 2 3 | 40% 43.3% | 93.3% 90% |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100245221A CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100245221A CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1596970A CN1596970A (en) | 2005-03-23 |
CN1302796C true CN1302796C (en) | 2007-03-07 |
Family
ID=34663544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100245221A Expired - Fee Related CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1302796C (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100400086C (en) * | 2005-12-13 | 2008-07-09 | 王忠民 | Medicine for treating low function of ovary |
CN100457177C (en) * | 2006-12-31 | 2009-02-04 | 蔡绪旺 | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney |
CN101474348B (en) * | 2008-12-07 | 2011-12-14 | 谭逢升 | Medicament for treating infertility |
CN101637258B (en) * | 2009-08-17 | 2012-05-23 | 北京同仁堂健康药业股份有限公司 | Health food used for improving immunity |
CN102462696B (en) * | 2010-11-03 | 2014-10-29 | 贺毅 | Purpose of black-bone silky fowl melanin extractive in preparation of medicament for controlling depression |
CN102008581B (en) * | 2010-12-09 | 2012-04-25 | 张跃宗 | Improved infant immunity decoction |
CN103478536A (en) * | 2013-08-13 | 2014-01-01 | 当涂县瑞龙果树种植专业合作社 | Anti-fatigue of purple sweet potato glutinous rice flour and preparation method thereof |
CN103444877B (en) * | 2013-09-15 | 2014-12-03 | 宁波市江东农茹生物科技有限公司 | Chickpea health-care nutrient powder with function of improving alimentary anemia |
CN103830610B (en) * | 2014-03-19 | 2016-01-20 | 高本梅 | A kind ofly treat that women is antenatal, the Chinese medicine of puerperal constipation |
CN105105246A (en) * | 2015-10-09 | 2015-12-02 | 张晓林 | Beverage capable of facilitating qi invigoration and blood nourishing of puerpera and preparation method thereof |
CN108671185A (en) * | 2018-07-03 | 2018-10-19 | 谢洁如 | A kind of drug and preparation method thereof for treating chronic fatigue syndrome |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096684A (en) * | 1993-06-16 | 1994-12-28 | 姜伟栋 | Lysium chinense and saussurea involucrata oral liquid |
-
2004
- 2004-07-26 CN CNB2004100245221A patent/CN1302796C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096684A (en) * | 1993-06-16 | 1994-12-28 | 姜伟栋 | Lysium chinense and saussurea involucrata oral liquid |
Also Published As
Publication number | Publication date |
---|---|
CN1596970A (en) | 2005-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101632827B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN1302796C (en) | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method | |
CN102133271B (en) | Medicinal tea for curing gout | |
CN1966052A (en) | Tablet containing red sage root and astragalus root for removing blood stasis and preparation process thereof | |
CN101856405B (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
CN102671178B (en) | Preparation method of Chinese medicinal composition for treating nephrotic syndrome and uremia and application thereof | |
CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
CN101953986B (en) | Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency | |
CN1264547C (en) | Preparation of Chinese traditional medicine for treating coronary heart disease and angina as well as preparation method | |
CN112717097A (en) | Traditional Chinese medicine composition for treating gastric cancer and preparation method thereof | |
CN1927315A (en) | Medicine for treating psoriasis mainly and its preparation method and use | |
CN1259078C (en) | Chinese medicine for treating women's chronic pelvic infection | |
CN102552519A (en) | Chinese medicine composition for activating blood and stopping pain, preparation process and application | |
CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
CN102205031B (en) | Traditional Chinese medicine for treating male sterility | |
CN1943691A (en) | A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method | |
CN101683421B (en) | Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection | |
CN1939494A (en) | Purge capsules for old person and production thereof | |
CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
CN1954877A (en) | Chinese medicinal composite for treating ischemic necrosis of femoral head and its preparation method | |
CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
CN102284036A (en) | Gujinwan capsule and preparation method thereof | |
CN103479868B (en) | Traditional Chinese medicine for treating apprehensive and cowardly arrhythmia and preparation method | |
CN1410110A (en) | Application of Chinese medicine containing sarcandra for treating side effect of anticancer medicine | |
CN100551404C (en) | Medicament for inducing diuresis to alleviate edema preparation of compositions and detection method and purposes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG C.P. FREDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LING PEIXUE Effective date: 20091225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091225 Address after: Lunan Road, hi tech Zone, Shandong, Ji'nan Patentee after: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. Address before: No. 264 mountain road, Lixia District, Shandong, Ji'nan Patentee before: Ling Peixue |
|
C53 | Correction of patent of invention or patent application | ||
C56 | Change in the name or address of the patentee | ||
CB03 | Change of inventor or designer information |
Inventor after: Ling Peixue Inventor after: Zhang Ling Inventor before: Ling Peixue Inventor before: Zhang Ling Inventor before: Qu Yanwei Inventor before: Liu Yanyan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LING PEIXUE ZHANG LING QU YANWEI LIU YANYAN TO: LING PEIXUE ZHANG LING |
|
CP03 | Change of name, title or address |
Address after: Hi tech District Ji'nan city Shandong province 250104 Road No. 3333 Patentee after: SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co.,Ltd. Address before: 250104 Lunan Road, Ji'nan hi tech Zone, Shandong Patentee before: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070307 |